Dr. Sidlow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-3100Fax+1 212-639-3000- Is this information wrong?
Summary
- I am a board-certified internal medicine specialist whose interest is in the care of cancer patients: co-management of complex patients undergoing chemotherapy, radiotherapy, and surgery; long term management of cancer survivors; management of patients at high risk for cancer (i.e. carriers of germline mutations; post-cancer treatment patients); preventive cardiology in patients with clonal hematopoesis.
Education & Training
- City of HopeCancer Genomic Risk, 2020 - 2021
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1998
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
- NY State Medical License 1996 - 2026
- NJ State Medical License 2017 - 2025
- CT State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- City of HopeCancer Genomics Risk Assessment
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 7 citationsThe Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care DeliveryKathleen R. Atlas, Barbara Egan, Caroline J. Novak, Robert Sidlow> ;The Oncologist. 2020 Dec 1
- 16 citationsThe experience of financial toxicity among advanced melanoma patients treated with immunotherapyBridgette Thom, Maha Mamoor, Jessica A. Lavery, Shrujal S. Baxi, Niloufer Khan, Lauren J. Rogak, Robert Sidlow, Deborah Korenstein> ;Journal of Psychosocial Oncology. 2021 Mar 4
- 24 citationsThe Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor.Robert Sidlow, Amy E. Lin, Dipti Gupta, Kelly L. Bolton, David P. Steensma, Ross L. Levine, Benjamin L. Ebert, Peter Libby> ;JAMA Cardiology. 2020 May 27
- Join now to see all
Journal Articles
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorRobert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
Authored Content
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020
Press Mentions
- Hereditary Cancers Aren’t Just a Women’s Problem. Jewish Men Need to Take Precautions TooNovember 28th, 2022
Professional Memberships
- Fellow
Other Languages
- Spanish
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: